At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 7,000 target
Drug / intervention
L-Arginine hydrochloridedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NCT06248359N/ARecruitingUpdate OverdueUpdated 14mo ago · Completion was 6mo agoEnrollment Stalled
Update Overdue
Association Between Early Postoperative L-Arginine Administration and Acute Kidney Injury Following Cardiac Surgery
In Brief
An observational study evaluating L-Arginine hydrochloride for Acute Kidney Injury. Currently recruiting, targeting 7,000 participants across 1 site.
Signals
Enrollment appears stalled
Detailed Summary
To investigate the association between the the early administration of L-Arginine after CPB-assisted cardiac surgery and the incidence of CS-AKI in adult patients. To test if it can reduce the incidence of post-operative AKI.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Kidney Injury
CountriesChina
Collaborators--
Timeline
N/ARecruitingOverdue
202420252026
Enrollment StartDec 2023
First PostedFeb 2024
Primary CompletionDec 2025
TodayJul 2026
First PostedFeb 8, 2024
Enrollment StartDec 1, 2023
Primary CompletionDec 1, 2025
TodayJul 1, 2026
Enrollment to primary: 2 yearsPosted 2.4 years ago
Interventions
L-Arginine hydrochloridedrug
Postoperative administration of L-Arginine hydrochloride before incidence of CS-AKI